ID
44776
Description
Study of STA-1 as an Add-on Treatment to Donepezil; ODM derived from: https://clinicaltrials.gov/show/NCT01255046
Link
https://clinicaltrials.gov/show/NCT01255046
Keywords
Versions (3)
- 8/30/15 8/30/15 -
- 4/13/21 4/13/21 - Dr. rer. medic Philipp Neuhaus
- 11/18/21 11/18/21 -
Copyright Holder
Sinphar Pharmaceutical Co., Ltd
Uploaded on
November 18, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Alzheimer Disease NCT01255046
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
Description
Exclusion Criteria
Description
brain image (computed tomography (ct) scan or magnetic resonance imaging (mri) done within past 12 months prior to the study) and laboratory tests to exclude secondary dementia or non-alzheimer's dementia;
Data type
boolean
Alias
- UMLS CUI [1]
- C0024485
- UMLS CUI [2]
- C0040405
- UMLS CUI [3]
- C0587081
Description
patient with significant clinically central nervous system illness other than ad (e.g. parkinson's disease, human immunodeficiency virus (hiv) induced dementia, hachinski ischaemic score (his) >4) or dementia complicated by other organic disease or delirium;
Data type
boolean
Alias
- UMLS CUI [1]
- C0007682
Description
patient with a severe or uncontrolled diagnostic and statistical manual of mental disorders (dsm-iv) axis i disorder other than alzheimer's disease, including amnestic disorders, schizophrenia or schizoaffective disorder, bipolar disorder, current major depressive episode, psychosis, panic, or post-traumatic stress disorder;
Data type
boolean
Alias
- UMLS CUI [1]
- C0004936
Description
patient suffering from cerebral disturbances following a stroke or a cerebral trauma (if the event occurred within the last 6 months);
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0038454
- UMLS CUI [1,2]
- C0234387
- UMLS CUI [2,1]
- C0018674
- UMLS CUI [2,2]
- C0234387
Description
patient with a history of hypersensitivity to study drugs;
Data type
boolean
Alias
- UMLS CUI [1]
- C0013182
Description
patient who has a history or evidence of a medical condition that would expose them to an undue risk of a significant adverse event or interfere with assessments of safety or efficacy during the course of the trial, including but not limited to hepatic, renal, respiratory, cardiovascular, endocrine (e.g., addison's disease), immune, neurologic, or hematologic disease as determined by the clinical judgment of the investigator;
Data type
boolean
Alias
- UMLS CUI [1]
- C3843040
Description
participation in any research study within the last 30 days;
Data type
boolean
Alias
- UMLS CUI [1]
- C0008976
Description
patient with significant alcohol or drug abuse as judged by the investigator.
Data type
boolean
Alias
- UMLS CUI [1]
- C0237123
Similar models
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
C0677408 (UMLS CUI [2])
C0040405 (UMLS CUI [2])
C0587081 (UMLS CUI [3])
C0234387 (UMLS CUI [1,2])
C0018674 (UMLS CUI [2,1])
C0234387 (UMLS CUI [2,2])